ProductProductWhat are Generics?
Abilify
view photo
Generic Abilify Aripiprazole 20mg

Generic Abilify is used for treating agitation caused by schizophrenia or bipolar disorder.


Mental Disorders


PackagePricePer pillSavingsOrder
20mg × 30 pills$89.80$ 2.99 
20mg × 60 pills$171.60$ 2.86  $8.00
20mg × 90 pills$236.40$ 2.63  $33.00
20mg × 120 pills$301.20$ 2.51  $58.00
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
I have received all of my order plus the bonus pills. You not only met my expectations but greatly exceeded them!
You properly set my expectations by providing me all the information that I would need during the ordering process and then followed up regularly to insure that all was occurring as it should.
Your focus on customer service is outstanding and has won me over as a long time customer. I have already recommended you to two of my friends and will continue to do so in the future. I am also very pleased with the quality of your product and accompanying reference materials that I received with my order.
I will do all of my medical business through your firm from this point forward. Thank you for your proactive efforts and strong customer focused business practices. I can honestly say my purchase experience has been outstanding! - Sincerely, Lloyd
Read more »Read more »
NewsNews
    Otsuka Wins Appeal Ruling Upholding Abilify Drug Patent - BusinessWeek
    Otsuka Wins Appeal Ruling Upholding Abilify Drug PatentBusinessWeek(BMY) (BMY) won an appeals court ruling that will help ward off generic-drug competition to their schizophrenia drug Abilify until April 2015
    Abilify Does Well in Depot Version - MedPage Today
    Abilify Does Well in Depot VersionMedPage TodayPHILADELPHIA -- A depot formulation of aripiprazole (Abilify) is on track to join the ranks of long-acting antipsychotic drugs that don't need to be taken daily, reports here suggested
    USA: FDA panel votes against Regeneron gout drug; Court upholds Abilify patent - The Pharma Letter
    USA: FDA panel votes against Regeneron gout drug; Court upholds Abilify patentThe Pharma LetterAbilify is partnered with USA-based Bristol-Myers Squibb (NYSE: BMY), for which the drug generated sales of $2
    Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment ... - MarketWatch (press release)
    Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment
    CBOE, Otsuka, Novozymes, Lamborghini: Intellectual Property - Bloomberg
    CBOE, Otsuka, Novozymes, Lamborghini: Intellectual PropertyBloombergOtsuka's Abilify Patent Upheld in US After Teva Appeal Otsuka Holdings Co
Live support Online Chat


Our billing is certified by
Secure shopping certificates